Evidence map›Paper›PMID 36678417›Full record

ArticlePathogens (Basel, Switzerland)2023

Effects of Immunization with Recombinant

Ana Carolina Maragno Fattori, Elisandra de A Montija, Bruna D de L Fragelli, Ricardo de O Correia, Cynthia Aparecida de Castro, Larissa Romanello, Camila T Nogueira, Silmara M Allegretti, Edson G Soares, Humberto D Pereira and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. HGPRT and PNP: Recombinant Enzymes fromPathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ana Carolina Maragno FattoriLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.ORCID 0000-0002-4868-9148
Elisandra de A MontijaLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.
Bruna D de L FragelliLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.ORCID 0000-0002-3970-7834
Ricardo de O CorreiaLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.
Cynthia Aparecida de CastroLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.
Larissa RomanelloDepartamento de Saúde e Psicologia, Universidade do Estado de Minas Gerais, Ituiutaba 38302-192, Brazil.
Camila T NogueiraDepartamento de Bioquímica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil.
Silmara M AllegrettiInstituto de Biologia, Departamento de Biologia Animal, Universidade Estadual de Campinas, Campinas 13083-970, Brazil.
Edson G SoaresLaboratório de Citopatologia, Departamento de Patologia e Medicina Legal, Universidade de São Paulo, Ribeirão Preto 14040-900, Brazil.
Humberto D PereiraInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos 13566-590, Brazil.
Fernanda de F AnibalLaboratório de Inflamação e Doenças Infecciosas, Departamento de Morfologia e Patologia, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.
Universidade Federal de São Carlos · BRUniversidade de São Paulo · BRUniversidade do Estado de Minas Gerais · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal de São Paulo · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) Finance Code 001São Paulo Research Foundation 2014/07331-5
6 · The paper itself

Abstract

Schistosomiasis is one of the most important human helminthiases worldwide. Praziquantel is the current treatment, and no vaccine is available until the present. Thus, the presented study aimed to evaluate the immunization effects with recombinant

Indexed as

Adenosine KinaseHypoxanthine-Guanine Phosphoribosyltransferaseimmunizationschistosomiasis mansoni

Identifiers

PMID36678417
PMCPMC9866087
OpenAlexW4313586742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.